Both revenue and net profit fell sharply, and Yifan Pharmaceutical was again questioned by investors for "low efficiency"


Full Data

?
UNLOCK DATA

Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets


Join Now!

Need this critical market data?

Access thousands of market events, data points, and news articles!


Already have an account?
Login